CS207573B2 - Method of preparatiob of 3-hydroxymethylenchromanone - Google Patents

Method of preparatiob of 3-hydroxymethylenchromanone Download PDF

Info

Publication number
CS207573B2
CS207573B2 CS782293A CS229378A CS207573B2 CS 207573 B2 CS207573 B2 CS 207573B2 CS 782293 A CS782293 A CS 782293A CS 229378 A CS229378 A CS 229378A CS 207573 B2 CS207573 B2 CS 207573B2
Authority
CS
Czechoslovakia
Prior art keywords
methyl
dimethyl
hydroxy
chromanone
methylene
Prior art date
Application number
CS782293A
Other languages
Czech (cs)
Inventor
Jasjit S Ibindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CS767070A external-priority patent/CS207571B2/en
Application filed by Pfizer filed Critical Pfizer
Priority to CS782293A priority Critical patent/CS207573B2/en
Publication of CS207573B2 publication Critical patent/CS207573B2/en

Links

Description

Předhozený vynález se týká způsobu přípravy 3-hydroxymethylenehromanonu obecného vzorce IThe present invention relates to a process for the preparation of 3-hydroxymethylenehromanone of the formula I

kdewhere

R4 a R5 jsou atomy vodíku, methyly nebo ethyly,R 4 and R 5 are hydrogen, methyl or ethyl,

Z je alky len s 1 až 9 atomy uhlíku nebo skupina —(alkjm—X—(alk2)n—, kde každý ze substituentů (alk,) a (alk2) obsahuje od 1 do 9 atomů uhlíku, přičemž součet atomů uhlíku v (alkj) a (alk2) je nejvýše 9, m a n je 0 nebo 1,Z is (C 1 -C 9) alkylene or - (alk (X) - (alk 2 ) n - wherein each of (alk,) and (alk 2 ) contains from 1 to 9 carbon atoms, the sum of the carbon atoms v (alkj) and (alk 2 ) is at most 9, m and n are 0 or 1,

X je O, S, SO nebo SO2 aX is O, S, SO or SO 2; and

W je methyl, fenyl, p-chlorfenyl, ρ-fluorfenyl, pyrldyl, piperidyl, cykhoalkyl s 3 až 7 atomy uhlíku, který je popřípadě imonosubstituovaný a kde substituenty jsou fe2 nyl, p-chlorfenyl nebo· p-fluorfenyl, přičemž jestliže W je methyl, je Z —- (allq )m—X— — (alk2)n, který se vyznačuje tím, že se sloučenina obecného vzorce IIW is methyl, phenyl, p-chlorophenyl, β-fluorophenyl, pyrldyl, piperidyl, cycloalkyl of 3 to 7 carbon atoms which is optionally immonosubstituted and wherein the substituents are phenyl, p-chlorophenyl or p-fluorophenyl, wherein W is methyl, is Z - (allq) m - X - (alk 2 ) n , characterized in that the compound of formula II

kdewhere

Rt, R4, R5, Z a W mají výše uvedený význam, nechá reagovat s ethylformiáte®.R 1 , R 4 , R 5 , Z and W are as defined above, reacted with ethyl formate ®.

Sloučeniny obecného vzorce I jsou nové sloučeniny, které jsou meziprodukty pro přípravu analgetických sloučenin.The compounds of formula I are novel compounds which are intermediates for the preparation of analgesic compounds.

Reakce se provádí přikapáním reakčních složek k suspensi hydridu sodného·, načež po· zředění etherem se reakce dokončí za varu.The reaction is carried out by dropwise addition of the reactants to the sodium hydride suspension, after which dilution with ether is complete by boiling.

Požadované výchozí sloučeniny obecného vzorce II se připraví z 3,5-dihydroxybenzooivé kyseliny následujícím reakčním sledem:The desired starting compounds of formula II are prepared from 3,5-dihydroxybenzoic acid by the following reaction sequence:

IIII

Výchozí materiál 3,5-dihydroxybenzoová kyselina (V) se převede na sloučeninu vzorce VI, kde Y2 je alkoxyl, vhodně methoxyl nebo eithoxyl pro snadnou přípravu, nebo aminoekupina a Yj je chráněná hydroxylová skupina, způsoby běžně známými z literatury.The starting material 3,5-dihydroxybenzoic acid (V) is converted to a compound of formula VI, wherein Y 2 is alkoxy, suitably methoxy or eithoxyl for ease of preparation, or amino and Y 1 is a protected hydroxyl group, by methods commonly known in the literature.

Jestliže Z je alkylen, Y;) je alkyl obsahující 1 až 4 atomy uhlíku nebo benzyl. Funkcí skupiny Yt se chrání hydroxyskupiny během následujících reakcí. Důležitější je jejich specifická funkce, to je chránění hydroxylové skupiny a ne jejich struktura. Výběr a identifikace příslušných chránících skupin může snadno provést odborník v oboru. Vhodnost a účinnost skupin, jakožto skupin pro chránění hydroxyskupin se stanovuje použitelností těchto skupin ve výše uvedeném reakčním sledu. Má to být tudíž skupina, ktedá se snadno odstraňuje, aby se obnovily hydroxylové skupiny. Jako chránicí alkylová skupina je výhodný methyl, neboť se snadno odstraňuje reakcí s pyridinhydrochloridem. JBenzylová skupina používaná pro chránění hydroxylové skupiny se odstraňuje katalytickou hydrogenolýzou nebo· kyselou hydrolysou.When Z is alkylene, Y;) is alkyl having 1 to 4 carbon atoms or benzyl. The function Y t are protected hydroxy groups during subsequent reactions. More important is their specific function, that is the protection of the hydroxyl group and not their structure. Selection and identification of appropriate protecting groups can be readily accomplished by one skilled in the art. The suitability and efficacy of the groups as hydroxy protecting groups is determined by the utility of these groups in the above reaction sequence. It is therefore to be a group that is easily removed to restore hydroxyl groups. Methyl is preferred as a protective alkyl group since it is readily removed by reaction with pyridine hydrochloride. The benzyl group used to protect the hydroxyl group is removed by catalytic hydrogenolysis or acid hydrolysis.

Jestliže Z je — (alktJm—X— (alk2Jn, je Y:l s výhodou benzyl nebo substituovaný benzyl, neboť se mohou snadno odstranit bez vlivu na skupinu Z.If Z is - (alk t J m - X - (alk 2 J n) , Y : 1 is preferably benzyl or substituted benzyl, since they can be easily removed without affecting the Z group.

Dvakrát chráněný derivát benzoové kyseliny (VIJ se pak převede na sloučeninu vzorce VIII známým způsobem. Při jednom postupu se sloučenina vzorce VI hydrolysuje na odpovídající kyselinu (Y2 = OH), nebo lithnoiu sůl a pak se nechá reagovat s příslušným alkyllithiem za vzniku alkylem disubstituovaného fenylketonu (Y2 = — alkyl). Jestliže se používá methyllithium, nechá se vzniklý acetofenonový derivát reagovat s Grignardovým reakčním činidlem (W-Z’-MgBr). Meziprodukt se hydrolysuje na odpovídající alkohol, který se pak hydrogenolysuje, aby se hydroxylová skupina nahradila za atom vodíku. Tento postup je zejména použitelný u těch sloučenin, kde Z je alkylen.The double protected benzoic acid derivative (VIJ is then converted to the compound of formula VIII in a known manner. In one method, the compound of formula VI is hydrolyzed to the corresponding acid (Y 2 = OH) or lithium salt and then reacted with the appropriate alkyl lithium to form an alkyl disubstituted phenyl ketone (Y 2 = - alkyl). When used methyllithium, allowed the resulting acetophenone derivative with a Grignard reagent (W-Z'-MgBr). the intermediate is hydrolyzed to the corresponding alcohol which is then hydrogenolysuje to replace the hydroxyl group with This procedure is particularly useful for those compounds wherein Z is alkylene.

Etherové skupiny se odstraňují vhodným způsobem: reakcí s pyridinhydrochloridem (Y, = methyl) nebo katalytickou hydrogenolysou (Yd = benzyl) nebo reakcí s kyselinou, jako je trifluoroctová kyselina, kyselina chlorovodíková, kyselina brornovodíková nebo' kyselina sírová nebo pyridinhydrochlorid. Kyselá debenzylace se samozřejmě používá jestliže skupina —Z—W obsahuje síru.The ether groups are removed in a suitable manner: by reaction with pyridine hydrochloride (Y = methyl) or catalytic hydrogenolysis (Y d = benzyl) or by treatment with an acid such as trifluoroacetic acid, hydrochloric acid, hydrobromic acid or sulfuric acid or pyridine hydrochloride. Of course, acid debenzylation is used when the —Z — W group contains sulfur.

Další metoda pro převádění sloučenin vzorce VI na sloučeniny vzorce VIII zahrnuje reakci ketonu vzorce VI (Y2 — alkyl) s příslušným derivátem trifenylfosfoniuimbromidu vzorce [ (C6H5)3P+_Z—WjBr- v přítomnosti báze (např. hydridu sodného). Reakce probíhá přes alken, který se pak katalyticky hydrogenuje na odpovídající alkan (Z—WJ a pak se odstraní chránicí skupiny a připraví se dihydroxysloučenina vzorce VIII. Jestliže —Z— je (alkjm—X—(alk2Jn a Yx je benzyl, vede katalytická hydrogenace také k štěpení benzyletherů.Another method for converting compounds of Formula VI to compounds of Formula VIII involves reacting a ketone of Formula VI (Y 2 -alkyl) with an appropriate triphenylphosphonium-bromide derivative of formula [(C 6 H 5 ) 3 P + -Z-W 3 Br - in the presence of a base (e.g. sodium hydride). The reaction proceeds through an alkene which is then catalytically hydrogenated to the corresponding alkane (Z-WJ and then deprotected and the dihydroxy compound of formula VIII is prepared. If -Z- is (alkim-X-) (alk 2 J n and Y x is benzyl) , catalytic hydrogenation also leads to the cleavage of benzyl ethers.

Alternativně převedení sloučenin vzorce VI na sloučeniny vzorce VIII se může provádět následujícím sledem VI->VII->VIII. V tomto sledu se dvakrát chráněný benzamid (VI, Y2 = NH2) převede na keton (VII, Z’ = Z bez jedné CH2-skupinyj reakcí s příslušným Grignardovým činidlem (BrMg— —Z’—Wj a pak reakcí s methyl- nebo ethylmagnesiumhalogenidem za vzniku odpovídajícího karbinolu. Dehydratace karbinolu například p-toluensulfonovoiu kyselinou vede k odpovídajícímu alkenu, který se pak katalyticky hydrogenuje (Pd/C) na alkan (VIII). Etherové skupiny se odstraní (převedou se na hydroxyskupinyj postupem popsaným výše.Alternatively, the conversion of compounds of formula VI to compounds of formula VIII can be carried out by the following sequence VI->VII-> VIII. In this sequence, the double-protected benzamide (VI, Y 2 = NH 2 ) is converted to the ketone (VII, Z '= Z without one CH 2 -group) by reaction with the appropriate Grignard reagent (BrMg-Z'-Wj and then reaction with methyl Dehydration of the carbinol with, for example, p-toluenesulfonic acid leads to the corresponding alkene, which is then catalytically hydrogenated (Pd / C) to the alkane (VIII), and the ether groups are removed (converted to hydroxy groups as described above).

Převedení sloučeniny vzorce VIII na 4-chromanon (IX) se provádí reakcí sloučeniny vzorce VIII s krotonovou kyselinou nebo kyselinou vzorce R4R5—C—CH—COOH v přítomnosti bortrifluorid-etherátu při teplotě od asi 20 do asi 125 °C. Krolmě sloučeniny vzorce IX se získá druhý produkt, isomerní se sloučeninou vzorce IX (7-hydroxy-2,2-R4Rr)-5-Z-W-4-chromanon).Conversion of the compound of formula VIII to 4-chromanone (IX) is accomplished by reacting the compound of formula VIII with crotonic acid or an acid of formula R 4 R 5 -C-CH-COOH in the presence of boron trifluoride etherate at a temperature of about 20 to about 125 ° C. Krol compound of formula IX to obtain a second product, the isomeric compound of Formula IX (7-hydroxy-2,2-R 4 R) -5-ZW-4-chromanone).

Předložený vynález je blíže objasněn v následujících příkladech.The present invention is illustrated by the following examples.

Příklad 1 dl-5-Hydroxy-2,2-dimethyl-7- (l-methyl-4-f enylbutyl) -4-chromanonExample 1 dl-5-Hydroxy-2,2-dimethyl-7- (1-methyl-4-phenylbutyl) -4-chromanone

Směs 2- (3,5-dihydroxyfenyl) -5-fenylpentanu (9,6 g) a 3-methylkrotonové kyseliny (5,6 g) se zahřívá na 125 °C v atmosféře dusíku a přidá se bortrifluorid-etherát (8,7 ml). Po jednohodinovém zahřívání k varu se reakční směs ochladí, přidá se voda (10 ml) a pak 6N hydroxid sodný (40 ml). Reakční směs se zahřívá 5 minut na parní lázni, ochladí se a okyselí 6 N kyselinou chlorovodíkovou. Vodná fáze se extrahuje etherem (3 x 100 ml) a spojené etherické extrakty se promyjí 10% roztokem hydrogenuhličitanu sodného (1 x 25 ml) a vodou (1 x 25 ml). Organická fáze se vysuší síranem sodným a zahuštěním ve vakuu se získá 12,7 g surového oleje, který se čistí chromatografií na silikagelu a získá se 5,0 g dl-5-hydroxy-2,2-dimethyl-7- (1-methyl-4-fenylbutyl)-4-chromanon ve formě bezbarvého oleje.A mixture of 2- (3,5-dihydroxyphenyl) -5-phenylpentane (9.6 g) and 3-methylcrotonic acid (5.6 g) was heated to 125 ° C under a nitrogen atmosphere and boron trifluoride etherate (8.7 g) was added. ml). After heating to boiling for 1 h, the reaction mixture was cooled, water (10 mL) was added, followed by 6N sodium hydroxide (40 mL). The reaction mixture was heated on a steam bath for 5 minutes, cooled and acidified with 6 N hydrochloric acid. The aqueous phase was extracted with ether (3 x 100 mL) and the combined ether extracts were washed with 10% sodium bicarbonate solution (1 x 25 mL) and water (1 x 25 mL). The organic phase was dried over sodium sulfate and concentrated in vacuo to give 12.7 g of a crude oil which was purified by silica gel chromatography to give 5.0 g of dl-5-hydroxy-2,2-dimethyl-7- (1-methyl). -4-phenylbutyl) -4-chromanone as a colorless oil.

IČ: (CHCI3) U — O 1635 cm1.IR: (CHCl 3) U - O 1635 cm -1 .

NMR: 1 ™sj3 NMR: 1 ™ with J3

1—1,7 (M, 7, α-methyl, ethylen],1 - 1.7 (M, 7, α-methyl, ethylene),

1,5 (S, 6, gem.dimethyl),1.5 (S, 6, gem.dimethyl),

2,3-2,9 (M, 3, benzylový methylen, methinyl ),2.3-2.9 (M, 3, benzyl methylene, methinyl),

2,65 (S, 2,, 05-methylen),2.65 (S, 2 ', 05-methylene),

6,1—6,35 (M, 2, aromatické protony),6.1-6.35 (M, 2, aromatic protons),

6,9-7,4 (M, 5, aromatické protony),6.9-7.4 (M, 5, aromatic protons),

11,53, 11,63 (d, 1, hydroxyl).11.53, 11.63 (d, 1, hydroxyl).

Obdobně se 2-(3,5-dihydroxyfenyl)-6-fenylhexan převede na dl-5-hydroxy-2,2-dimethyl-7- (l-methyl-5-f enylpentyl) -4-chromanon (olej):Similarly, 2- (3,5-dihydroxyphenyl) -6-phenylhexane is converted to dl-5-hydroxy-2,2-dimethyl-7- (1-methyl-5-phenylpentyl) -4-chromanone (oil):

1,2 (d, 3, «-methyl, J — 7 cps),1.2 (d, 3, N-methyl, J = 7 cps),

1,4 (S, 6, gem.dimethyl),1.4 (S, 6, gem.dimethyl),

I, 0-1,9 [M, 6, 0-CH2-(CH2)3-C(CH3j-Ar],I, 0-1,9 [M, 6,0-CH 2 - (CH 2 ) 3 -C (CH 3 j-Ar),

2,3—2,8 (M, 3, benzylový methylen, me thinyl),2,3-2,8 (M, 3, benzyl methylene, methyl),

2,7 (S, 2, «-methylen),2.7 (S, 2, N-methylene),

6,2—6,4 (M, 2, aromatické protony),6.2-6.4 (M, 2, aromatic protons),

7,1-7,3 (5, aromatické protony),7.1-7.3 (δ, aromatic protons),

II, 6 (S, 1, hydroxyl),II.6 (S, 1, hydroxyl),

1- (3,5-dihydroxyfenyl) -2-fenylethan se převede na 5-hydroxy-2,2-d:imethyl-7-(2-fenylethyl) -4-chromanon (olej):1- (3,5-Dihydroxyphenyl) -2-phenylethane was converted to 5-hydroxy-2,2-d: Imethyl-7- (2-phenylethyl) -4-chromanone (oil):

IC: (CHC13) C = O 1645 cm1 IC: (CHCl 3 ) C = O 1645 cm -1

1,45 (S, 6, gem.dimethyl),1.45 (S, 6, g. Dimethyl),

2,65 (S, 2, «-methylen),2.65 (S, 2'-methylene),

2,85 (S, 4, ethylen),2.85 (s, 4, ethylene),

6,25, 6,3 (2d, 2, aromatické protony),6.25, 6.3 (2d, 2, aromatic protons),

7,2 (S, 5, aromatické protony),7.2 (S, 5, aromatic protons),

11,6 (S, 1, hydroxyl-D2O překrytí).11.6 (S, 1, hydroxyl-D 2 O overlap).

MS: molekulární ion 296.MS: molecular ion 296.

2- (3,5-Dihydroxyf enyl) -4-fenylbutan se převede na dl-5-hydroxy-2,2-dimethyl-7- (l-methyl-3-f enylpropyl) -4-chromanon (olej):2- (3,5-Dihydroxyphenyl) -4-phenylbutane was converted to dl-5-hydroxy-2,2-dimethyl-7- (1-methyl-3-phenylpropyl) -4-chromanone (oil):

1,3 (d, 3, methyl),1.3 (d, 3, methyl),

1,45 (S, 6, gem.dimethyl),1.45 (S, 6, g. Dimethyl),

I, 55—2,1 (M, 2, methylen),I, 55-2.1 (M, 2, methylene),

2,25—2,75 (M, 3, benzylový methylen, methinyl),2.25-2.75 (M, 3, benzyl methylene, methinyl),

6,15 (d, 2, aromatické protony),6.15 (d, 2, aromatic protons),

7,1 (S, 5, aromatické protony),7.1 (S, 5, aromatic protons),

II, 6 (S, 1, hydroxyl-D2O překrytí).II, 6 (S, 1, hydroxyl-D 2 O overlay).

MS: molekulární ion 324.MS: molecular ion 324.

2- (3,5-Dihydroxyf enyl) -5-f enylpentan (5,27 g) se převede reakcí s bortrifluorid-etherátem (4,81 ml) a kyselinou krotonovou (2,08 g čerstvě destilované) místo s2- (3,5-Dihydroxyphenyl) -5-phenylpentane (5.27 g) was converted by reaction with boron trifluoride etherate (4.81 ml) and crotonic acid (2.08 g freshly distilled) instead of s

3-methylkrotonovou kyselinou na dl-5-hydroxy-2-toethyl-7-(l-methyl-4-fenylbutyl)-4-chromanon:3-methylcrotonic acid to dl-5-hydroxy-2-ethyl-7- (1-methyl-4-phenylbutyl) -4-chromanone:

NMR: óNMR: .delta

TMSTMS

CDC13CDC13

1,1 (D, 3, α-methyl, J = 7 Hz),1.1 (D, 3, α-methyl, J = 7Hz),

1.4 (D, 3, 2-methyl, J = 7 Hz),1.4 (D, 3,2-methyl, J = 7Hz)

I, 3-1,8 (M, 4-eťhylen),I, 3-1.8 (M, 4-ethylene),

2,2-2,9 (M, 5, «-methylen, benzylový methylen, methinyl),2.2-2.9 (M, 5'-methylene, benzyl methylene, methinyl),

4.5 (Μ, 1, methinyl ether),4.5 (Μ, 1, methinyl ether)

6,1, 6,2 (2, D, aromatické protony, J = = 1 Hz),6.1, 6.2 (2, D, aromatic protons, J = 1 Hz),

6,9-7,4 (M, 5, aromatické protony),6.9-7.4 (M, 5, aromatic protons),

II, 7 (S, 1, fenolický OH).II, 7 (S, 1, phenolic OH).

4- (3,5-Dihydroxyfenyl) -1-f enoxypentan se převede na dl-5-hydroxy-2,2-dimethyl-7- (l-methyl-4-f enoxybutyl) -4-chromanon, světle žlutý olej:4- (3,5-Dihydroxyphenyl) -1-phenoxypentane was converted to dl-5-hydroxy-2,2-dimethyl-7- (1-methyl-4-phenoxybutyl) -4-chromanone, light yellow oil:

MS: molekulární ion 354.MS: molecular ion 354.

Rf = 0,61 (silikagel, benzen-ethylacetát 18 : 1)R f = 0.61 (silica gel, benzene-ethyl acetate 18: 1)

Analýza pro C22H26O4:Analysis for C22H26O4:

vypočteno:calculated:

74.55 % C, 7,39 % H;74.55% C, 7.39% H;

nalezeno:found:

74.56 % C, 7,36 % H.74.56% C, 7.36% H.

4- (3,5-Dihydroxyfenyl) -1- (4-pyridyl j pentan se převede na dl-5-hydroxy-2,2,-dimethyl-7- [ l-methyl-4- (4-pyridyl) butyl ] -4-chrclmamon olej:4- (3,5-Dihydroxyphenyl) -1- (4-pyridyl) pentane was converted to dl-5-hydroxy-2,2'-dimethyl-7- [1-methyl-4- (4-pyridyl) butyl] -4-chrclmamone oil:

Rf = 0,39 (silikagel, benzen-ethylacetát 1 : : 1)R f = 0.39 (silica gel, benzene-ethyl acetate 1: 1)

NMR: SNMR: .delta

1—1,90 (Μ, 13-H, methylen, methyl dublet při 1,20, J = 7 Hz, a gem.dimethyl singlet při 1,5),1 - 1.90 (Μ, 13-H, methylene, methyl doublet at 1.20, J = 7 Hz, and gem.dimethyl singlet at 1.5),

2,43—2,86 (Μ, 5-H, methylen, methinyl, včetně singletu (dva C-3 H při 2,71),2.43-2.86 (Μ, 5-H, methylene, methinyl, including singlet (two C-3 H at 2.71),

6,26 (b.d. S, 1-H, aromatický proton), 6,33 (b.d S, 1H, aromatický proton), 7,00—7,20 (b. d. D, 2-H, pyridin aromatické protony),6.26 (b.d. S, 1-H, aromatic proton), 6.33 (b.d S, 1H, aromatic proton), 7.00-7.20 (b. D. D, 2-H, pyridine aromatic protons),

7,25 (b.d. 1, 1-H- hydroxyl),7.25 (bd., 1,1-H-hydroxyl),

8,41—8,61 (b.d. D, 2-H-pyridin aromatické protony).8.41-8.61 (b.d. D, 2-H-pyridine aromatic protons).

dl-5-Hydro>xy-2,2-dimethyl-7- (1-methyl-3-feníoxypropyl)-4-chromanon se připraví z 3-(2,5-dihydroxyfenyl)-l-fenoxybutan!u ve formě oleje.dl-5-Hydroxy-2,2-dimethyl-7- (1-methyl-3-phenoxypropyl) -4-chromanone was prepared from 3- (2,5-dihydroxyphenyl) -1-phenoxybutanol as an oil .

Rf = 0,7 (silikagel, benzen-ethylacetát 18 : :1).R f = 0.7 (silica gel, benzene-ethyl acetate 18: 1).

MS: molekulární ion 340.MS: molecular ion 340.

Analýza proi C21H24O4:Analysis for C21H24O4:

vypočteno:calculated:

74,09 % C, 7,11 % H; nalezeno:% C, 74.09;% H, 7.11; found:

74,04 % C, 7,19 % H.% C, 74.04;% H, 7.19.

dl-2- (3,5-Dihydroxyfenyl) -1- (2-fenylethoxy) propan se převede na dl-2,2-dimethyl-5-hydroxy-7- (l-methyl-2- (2-fenylethoxy j ethyl ] -4-chromanon (olej).dl-2- (3,5-Dihydroxyphenyl) -1- (2-phenylethoxy) propane was converted to dl-2,2-dimethyl-5-hydroxy-7- (1-methyl-2- (2-phenylethoxy) ethyl) -4-Chromanone (oil).

1,21 (d, J = 7 Hz, methyl), 1,48 (s, gem.dlmethyl),1.21 (d, J = 7 Hz, methyl), 1.48 (s, g-dimethyl),

2,73 (s, C-3 methylen),2.73 (s, C-3 methylene),

2,86 (+, J = 7 Hz, CH2Ph),2.86 (+, J = 7 Hz, CH 2 Ph),

2,9 (m, miethin),2.9 (m, miethin),

3,50 (d, J = 7 Hz, -CH2O-),3.50 (d, J = 7Hz, -CH 2 O-)

3,65 (t, J = 7 Hz, -OCH2-), 6,31 (d, J = 1 Hz, ArH), 6,38 (d„ J = 1 Hz, ArH),3.65 (t, J = 7Hz, -OCH2 -), 6.31 (d, J = 1Hz, ArH), 6.38 (d, J = 1Hz, ArH),

7,26 (s, Phj a 13,33 (s, fenol).7.26 (s, Phj and 13.33 (s, phenol)).

Příklad 2 dl-5-Hydroxy-3-hydroxyraethylen-2,2-dimethyl-7- (l-methyl-4-fenylbutyl) -4-chromanonExample 2 dl-5-Hydroxy-3-hydroxyraethylene-2,2-dimethyl-7- (1-methyl-4-phenylbutyl) -4-chromanone

K hydridu sodnému připravenému promytím 50 % hydridu sodného v minerální olejové dispersi (6,67 g) pentanem se přikape během 30 minut roztok dl-5-hydroxy-2,2-dimethyl-7- (l-methyl-4-f enylbutyl J -4-chromanonu (4,7 g) a ethylformiátu (23,1 g). Reakční směs se pak ochladí na teplotu místnosti a přidá se -ether (350 ml). Vzniklá směs se zahřívá 18 hodin k varu, ochladí se na teplotu místnosti a okyselí se 1 N kyselinou chlorovodíkovou. Etherická fáze se oddělí a vodná fáze se extrahuje etherem (3 x 100 ml). Spojené etherické extrakty se vysuší síranem sodným a zahuštěním ve vakuu se získá 5,7 g dl-5-hydroxy-3-hydroxymethylen-2,2-dimethyl-7- (l-methyl-4-fenylbutyl) -4-chrolmanqnu ve formě oleje.A solution of dl-5-hydroxy-2,2-dimethyl-7- (1-methyl-4-phenylbutyl) was added dropwise over 30 minutes to the sodium hydride prepared by washing the 50% sodium hydride in a mineral oil dispersion (6.67 g) with pentane. Of 4-chromanone (4.7 g) and ethyl formate (23.1 g), the reaction mixture was then cooled to room temperature and -ether (350 mL) was added and the mixture was heated at reflux for 18 hours. The ethereal phase was separated and the aqueous phase was extracted with ether (3 x 100 mL). The combined ethereal extracts were dried over sodium sulfate and concentrated in vacuo to give 5.7 g of dl-5-hydroxy-3. hydroxymethyl-2,2-dimethyl-7- (1-methyl-4-phenylbutyl) -4-chloroanine as an oil.

1,05—1,8 (M, 13, gem.dimethyl, α-meťhyl, ethylen),1,05-1,8 (M, 13, g-dimethyl, α-methyl, ethylene),

2,45 (M, 3, benzylový methylen, methinyl),2.45 (M, 3, benzyl methylene, methinyl),

6,2—6,5(M, 2, ArH),6.2 - 6.5 (M, 2, ArH),

7,0—7,6 (M, 6, ArH, methinyl ether),7.0-7.6 (M, 6, ArH, methinyl ether),

11.3, 11,36 (2 b.d. S, 1, fenolický hydroxyl),11.3, 11.36 (2 d.d. of S, 1, phenolic hydroxyl),

13.3, 13,5, (2 b.d. S, 1, hydroxyl).13.3, 13.5, (2 d.d. of S, 1, hydroxyl).

IČ: (CHCI3) C = O 1625 cm1.IR: (CHCl 3) C = O 1625 cm -1 .

Stejným způsobem se produkty příkladu 1 převedou na dl-5-hydroxy-3-hydroxymethylen-2,2-dimeithyl-7- (l-methyl-5-fenylpentyl) -4-chromanon:In the same manner, the products of Example 1 were converted to dl-5-hydroxy-3-hydroxymethylene-2,2-dimethyl-7- (1-methyl-5-phenylpentyl) -4-chromanone:

1,2 (D, 3, «-methyl, J = 7 cps),1.2 (D, 3, N-methyl, J = 7 cps),

1,6 (S, 6, gem.dítoethyl),1.6 (S, 6, gem.diethyl),

1,0-2,0 [M, 6, 0CH2-(CH2)3-CH(CH3)Ar],1.0-2.0 [M, 6, 0CH2- (CH2) 3-CH (CH3) Ar]

2,3-2,8 (Μ, 3, benzylový methylen, methinyl },2,3-2,8 (Μ, 3, benzyl methylene, methinyl},

6,2-6,4 (M, 2, ArH),6.2-6.4 (M, 2, Ar H),

7,1-7,4 (M, 6, ArH, vinylový proton),7.1-7.4 (M, 6, ArH, vinyl proton),

11,4 (bdS, 1, fenolický hydroxyl),11.4 (bdS, 1, phenolic hydroxyl),

5-hydroxy-3-hydroxymethylen-2,2-dimeth;yl-7- (2-fenylefhyl) -4-chromanon (olej):5-Hydroxy-3-hydroxymethylene-2,2-dimethyl-7- (2-phenylphenyl) -4-chromanone (oil):

IC: (CHCLj) C = O 1625 cm1.IC: (CHCl 3) C = O 1625 cm -1 .

1,5 (S, 6, gem.dimethyl),1.5 (S, 6, gem.dimethyl),

2,85 (S, 4, ethylen),2.85 (s, 4, ethylene),

6,2, 6,3 (d, 2, ArH),6.2, 6.3 (d, 2, ArH),

7,0-7,5 (M, 6, ArH, methinyl),7.0-7.5 (M, 6, ArH, methinyl),

11,35 (S, 1, hydroxyl-DgO překrytí),11.35 (S, 1, hydroxyl-DgO overlay),

13,4, 13,6 (d, 1, hydroxyl-D2O překrytí).13.4, 13.6 (d, 1, hydroxyl-D 2 O overlap).

MS: molekulární ion 324.MS: molecular ion 324.

dl-5-Hydro«y-3-hydroxymethylen-2,2-diihethyl-7- (l-methyl-3-fenylpropyl) -4-chroimanoin (olej):dl-5-Hydroxy-3-hydroxymethylene-2,2-diethyl-7- (1-methyl-3-phenylpropyl) -4-chroimanoin (oil):

1,15 (d, 3, methyl),1.15 (d, 3, methyl),

1,5 (S, 6, gem.dimethyl),1.5 (S, 6, gem.dimethyl),

I, 65—2,1 (M, 2, methylen),I, 65-2.1 (M, 2, methylene),

2,25—2,75 (M, 3, benzylový methylen, methinyl),2.25-2.75 (M, 3, benzyl methylene, methinyl),

6,15, 6,3 (2d, 2, ArH),6.15, 6.3 (2d, 2, ArH),

7,1 (M, 6, ArH, olefinický proton),7.1 (M, 6, ArH, olefinic proton),

II, 3 (S, 1, hydroxyl-D20 překrytí),II, 3 (S, 1, hydroxyl-D 20 overlap),

13,3, 13,8 (d, 1, hydroxyl-D2O překrytí). MS: molekulární ion 352.13.3, 13.8 (d, 1, hydroxyl-D 2 O overlap). MS: molecular ion 352.

dl-5-Hydroxy-3-hydroxymethylen-2-methyl-7- (l-methyl-4-fenylbutyl) -4-chromanon:dl-5-Hydroxy-3-hydroxymethylene-2-methyl-7- (1-methyl-4-phenylbutyl) -4-chromanone:

1,1 (D, 3, «-methyl, J = 7 Hz),1.1 (D, 3'-methyl, J = 7 Hz),

1,5 (D, 3,2-m!ethyl, J = 7 Hz),1.5 (D, 3.2-methyl, J = 7 Hz),

1.3- 1,8 (M, 4-ethylen),1.3-1.8 (M, 4-ethylene),

2.3- 2,9 (M, 3, benzylové protony),2.3-2.9 (M, 3, benzylic protons),

4,9 (Μ, 1, methinyl ether, J = 5 Hz),4.9 (Μ, 1, methynyl ether, J = 5 Hz),

6,2, 6,3 (2D, 2, ArH, J = 1 Hz),6.2, 6.3 (2D, 2, ArH, J = 1Hz),

6,9-7,4 (M, 6, ArH, vinylový proton),6.9-7.4 (M, 6, ArH, vinyl proton),

11,2 (b.d. S, 1, feholický OH).11.2 (b.d. S, 1, feholic OH).

dl-5-Hydroxy-2,2-dimethyl-7- (1-methyl-4-f enoxybutyl) -4-chromanon se převede na dl-5-hydroKy-3-hydroxymethylen-2,2-dimethyl-7- (l-methýl-4-f enoxybutyl )-4-chrornanon:dl-5-Hydroxy-2,2-dimethyl-7- (1-methyl-4-phenoxybutyl) -4-chromanone was converted to dl-5-hydroxy-3-hydroxymethylene-2,2-dimethyl-7- ( 1-Methyl-4-phenoxybutyl) -4-chromonanone:

Rf = 0,44 [silikagel, benzen-ethylacetát 18 : Rf = 0.44 [silica gel, benzene-ethyl acetate 18:

: 1].: 1].

MS: molekulární ion 382.MS: molecular ion 382.

dl-5-Hydroxy-2,2-dimethyl-7- [ 1-methyl-4- (4-pyridyl) blutyl ] -4-chromanon se pře10 vede na dl-5-hydroxy-3-hydroxymethylen-2,2-dimethyl-7- [ l-methyl-4- (4-pyridyl) butyl] -4-chromanon, viskosní olej.dl-5-Hydroxy-2,2-dimethyl-7- [1-methyl-4- (4-pyridyl) blutyl] -4-chromanone was converted to dl-5-hydroxy-3-hydroxymethylene-2,2- dimethyl 7- [1-methyl-4- (4-pyridyl) butyl] -4-chromanone, viscous oil.

Rf — 0,15 (silikagel, benzen-ethylacetát 1 :1).R f = 0.15 (silica gel, benzene-ethyl acetate 1: 1).

dl-2,2-Dimethyl-5-hydroxy-7-[l-methyl-2- (2-fenylethoxyj ethyl ] -4-chromanoin se převede na dl-2,2-dime!thyl-3-hydroxymethylen-5-hydr oxy-7- [ l-methyl-2- (2-fenylethoKy )ethyl ] -4-chromanon (olej).dl-2,2-Dimethyl-5-hydroxy-7- [1-methyl-2- (2-phenylethoxy) ethyl] -4-chromanoin is converted to dl-2,2-dimethyl-3-hydroxymethylene-5- hydroxy-7- [1-methyl-2- (2-phenylethyl) ethyl] -4-chromanone (oil).

Rf — 0,35 (silikagel, 1 : 1 pentan : ether).Rf = 0.35 (silica gel, 1: 1 pentane: ether).

Příklad 3 dl-5-Hydroxy-2,2-dimethyl-7- (2-heptyloxy) -4-chromanoinExample 3 dl-5-Hydroxy-2,2-dimethyl-7- (2-heptyloxy) -4-chromanoin

K roztoku 5,7-dihydroxy-2,2-dimethyl-4-chromanonu (18,5 g, 87,1 mmoil) a hydroxidu draselného (2,44 g, 43,5 mmol) v N,N-dimethylformiamidu (58 ml) se za míchání přidá 2-brOmhfeiptan (15,77 g, 88,0 mmol). Směs se 4 dny zahřívá na 100 °C, ochladí se na teplotu místnosti a pak se přidá do směsi vodného hydroxidu sodného (110 ml, 1N), vbidy (45 mil) a chloroformu (150 ml). Směs se míchá a chloroformová fáze se oddělí. Vodná fáze se extrahuje dalším množstvím chloroformu (150 ml). Spojené chloirofofmové fáze se promyjí 1N roztokem hydroxidu sodného (2 x 100 ml), vysuší se síranem sodným a zahustí se na olej ovitý odparek. Nezreagovaný 2-bromheptan se odstraní destilací a odparek se čistí chromatografií na silikagelu a získá se 6,90 g (22,1 %) sloučeniny uvedené v nadpisu ve formě oleje.To a solution of 5,7-dihydroxy-2,2-dimethyl-4-chromanone (18.5 g, 87.1 mmol) and potassium hydroxide (2.44 g, 43.5 mmol) in N, N-dimethylformamide (58). ml) 2-bromo-heptiptan (15.77 g, 88.0 mmol) was added with stirring. The mixture was heated at 100 ° C for 4 days, cooled to room temperature and then added to a mixture of aqueous sodium hydroxide (110 mL, 1N), pyridine (45 mL) and chloroform (150 mL). The mixture was stirred and the chloroform phase was separated. The aqueous phase was extracted with an additional amount of chloroform (150 mL). The combined chloirophof phases were washed with 1N sodium hydroxide solution (2 x 100 ml), dried over sodium sulfate and concentrated to an oily residue. The unreacted 2-bromoheptane was removed by distillation and the residue was purified by silica gel chromatography to give 6.90 g (22.1%) of the title compound as an oil.

NMR: (CDC13) á 12,4 (jednoprototnový singlet, hydroxyl],NMR: (CDCl 3 )? 12.4 (one-pot singlet, hydroxyl],

5.7 a 6,0 (dva jednoprotonové dublety5.7 and 6.0 (two single proton doublets)

J = 3 Hz, arolmatické protony j,J = 3 Hz, arolmatic protons j,

4,1—4,7 (jednoprotonový multiplet, etherický methinj,4.1—4.7 (single proton multiplet, ethereal methinj,

2.7 (dvouprotonový singlet, C-3 methylen),2.7 (2-proton singlet, C-3 methylene),

0,7-2,0 (22 protonů, multiplet zbývajících proťoínů, gem.dimethyl objevující se jako; singlet při 1,5).0.7-2.0 (22 protons, multiplet of remaining procoins, gem.dimethyl appearing as; singlet at 1.5).

Stejným způsobem se dl-5-hydroxy-2,2-dimethyl-7- [ 2- (5-f enyl j pentyloíxy ] -4-chromanon připraví záměnou 2-brom-5-fenlylpentantu za 2-bromheptanj, t. t. 83 až 84 °C.In the same manner, dl-5-hydroxy-2,2-dimethyl-7- [2- (5-phenylpentyloxy) -4-chromanone was prepared by substituting 2-bromo-5-phenylypentant for 2-bromoheptane, mp 83-84 Deň: 32 ° C.

IČ: (KBrj C = O 1639 cm1.IR: (KBrj C = O 1639 cm -1 ) .

NMR: <SNMR: .delta

TMSTMS

CDC15CDC15

1,3 (D, 3, «-methyl, J = 7 Hz],1.3 (D, 3, N-methyl, J = 7 Hz),

1,3—2,0 (M, 4, ethylen],1.3-2.0 (M, 4, ethylene),

1,5 (S, 6, gem.dimethyl),1.5 (S, 6, gem.dimethyl),

2,7 (S, 2, «-methylen),2.7 (S, 2, N-methylene),

2,5—2,9 {Μ, 2, benzylový methylen],2,5-2,9 {Μ, 2, benzyl methylene],

4.1- 4,7 (Μ, 1, methin),4.1- 4.7 (Μ, 1, methine),

5,9-6,1 (Μ, 2, ArH),5.9-6.1 (Μ, 2, ArH),

6.1- 7,5 (Μ, 5, ArH),6.1-7.5 (Μ, 5, ArH)

12,2 (S, 1, fenolický proton).12.2 (S, 1, phenolic proton).

MS: (molekulární ion) 354.MS: (molecular ion) 354.

Analýza pro C22H26O4: vypočteno:Analysis for C 22 H 26 O 4: calculated:

74,55 % C, 7,39 % H; nalezeno:74.55% C, 7.39% H; found:

74,68 % C, 7,46 % H. dl-5-Hydroxy-2,2-dimethyl-7- (1-methyl-3-fenylpropoxy)-4-chromanon se připraví z 2-brom-4-fenylbutanu jako olej:74.68% C, 7.46% H. dl-5-Hydroxy-2,2-dimethyl-7- (1-methyl-3-phenylpropoxy) -4-chromanone was prepared from 2-bromo-4-phenylbutane as oil:

NMR: á ™s NMR: á ™ s

U ODCb U ODCb

1,25, 1,35 (d, 3, methyl),1.25, 1.35 (d, 3, methyl),

1,4 (S, 6, gem.dimethyl),1.4 (S, 6, gem.dimethyl),

1,6-2,4 (M, 2, methylen),1.6-2.4 (M, 2, methylene),

2,6 (S, 2, benzylový methylen),2.6 (S, 2, benzyl methylene),

2,85 (S, 2, 3 a-methylen),2.85 (S, 2, 3 α-methylene),

4,05—4,7 (M, 1, methinyl),4.05-4.7 (M, 1, methinyl),

5,9 (5d, 2, ArH),5.9 (5d, 2, ArH),

7,25 (S, 5, ArH).7.25 (s, 5, ArH).

dl-5-Hydroxy-2,2-dimethyl-7-cyklohexyloxy-4-chromanon se připraví z bromcyklohexanu, t. t. 72 až 75 °C.dl-5-Hydroxy-2,2-dimethyl-7-cyclohexyloxy-4-chromanone was prepared from bromocyclohexane, mp 72-75 ° C.

IČ (KBr) C = 0 1626 cm1, OH 3390 cm1. MS: (molekulární ion) 290.IR (KBr) C = 0 1626 cm -1 , OH 3390 cm -1 . MS: (molecular ion) 290.

NMR: á ™s ΐΊΐνιιχ. u c[)cl3 NMR: á ™ with ΐΊΐνιιχ. u c [] cl3

1—2,1 (M, 10, C5H10-cyklohexyi),1-2.1 (M, 10, C 5 H 10 -cyclohexyl),

I, 4 (S, 6, gem.dimethyl),1,4 (S, 6, g. Dimethyl),

2,65 (S, 2, a-methylen),2.65 (S, 2, .alpha.-methylene),

4,0—4,45 (M, 1, cyklohexylmethinyl), 5,85—6,05 (M, 2, ArH),4.0-4.45 (M, 1, cyclohexylmethinyl), 5.85-6.05 (M, 2, ArH),

II, 9 (S, hydroxyl, D2O překrytí).II, 9 (S, hydroxyl, D 2 O overlap).

Příklad 4 dl-5-Hydroxy-3-hydroxymethylen-2,2-dimethyl-7- (2-heptyloxy) -4-chromanonExample 4 dl-5-Hydroxy-3-hydroxymethylene-2,2-dimethyl-7- (2-heptyloxy) -4-chromanone

K hydridu sodnému získanému promytím 9,23 g (192 mmiol) 50 % hydridu sodného v dispersi minerálního oleje V pentanu se během 30 minut přikape roztok dl-5-hydroxy-2,2-dimethyl-7-( 2-heptyloxy )-4-chromanoinu (5,90, 19,2 mmol) v ethylfonmiátu, 34,9 ml (432 mmol). Po skončení přidávání se přidá ether (475 ml) a vzniklá směs se zahřívá k varu. Po 18 hodinách se reakění směs ochladí na teplotu místnosti a okyselí se 1N kyselinou chlorovodíkovou. Organická fáze se oddělí a vodná fáze se dále extrahuje etherem (3 x 125 ml). Spojené etherické extrakty se vysuší síra12 nem sodným a zahuštěním ve vakuu se získá 6,41 g (>100 °/o) dl-5-hydroxy-3-hydroxymethylen-2,2-dimethyl-7-(2-heptyloxy )-4-cbromanon ve formě oleje.To the sodium hydride obtained by washing 9.23 g (192 mmol) of 50% sodium hydride in a mineral oil dispersion in pentane was added dropwise a solution of dl-5-hydroxy-2,2-dimethyl-7- (2-heptyloxy) -4 over 30 minutes. -chromanoin (5.90, 19.2 mmol) in ethyl formate, 34.9 mL (432 mmol). After addition was complete, ether (475 mL) was added and the resulting mixture was heated to reflux. After 18 hours, the reaction was cooled to room temperature and acidified with 1N hydrochloric acid. The organic phase was separated and the aqueous phase was further extracted with ether (3 x 125 mL). The combined ethereal extracts were dried with sodium sulfate and concentrated in vacuo to give 6.41 g (> 100%) of dl-5-hydroxy-3-hydroxymethylene-2,2-dimethyl-7- (2-heptyloxy) -4 -bromanone in the form of an oil.

NMR: 5 ™csi3 NMR: 5 ™ C i3

13,4 (jeden proton široký singlet, hydroxyl),13.4 (one proton wide singlet, hydroxyl),

11,8 (jeden proton, singlet, fenolický hydroxyl),11.8 (one proton, singlet, phenolic hydroxyl),

7,4 (jednoprotonový široký singlet, vinyl),7.4 (single proton wide singlet, vinyl)

6,1, 6,0 (dva jednoprotonové dublety,6.1, 6.0 (two single proton doublets,

J = 3 Hz, aromatické protony),J = 3 Hz, aromatic protons),

4,8-4,2 (jednoprotonový multiplet, methin),4.8-4.2 (single proton multiplet, methine),

2,1-0,7 (20 protonů, multiplet zbývajících protonů).2.1-0.7 (20 protons, multiplet remaining protons).

Stejným způsobem se příslušné reakění složky podle příkladu 3 převedou na dl-5-hydroxy-3-methylen-2,2-dimethyl-7- [ 2- (5-fenyl) pentyloxy ] -4-chromanon, olej.In the same manner, the appropriate reaction of the component of Example 3 was converted to dl-5-hydroxy-3-methylene-2,2-dimethyl-7- [2- (5-phenyl) pentyloxy] -4-chromanone, an oil.

NMR: S ™«l3 NMR: .delta

1,3 (D, 3, methyl, J = 7 Hz),1.3 (D, 3, methyl, J = 7Hz),

1.3- 2,0 (M, 4, ethylen),1.3-2.0 (M, 4, ethylene),

1,4 (S, 6, gem.dimethyl),1.4 (S, 6, gem.dimethyl),

2.3- 2,8 (b.d. T, 2-henzylový methylen),2.3- 2.8 (b.d. T, 2-henzyl methylene),

4,1—4,7 (M, 1, methin),4.1-4.7 (M, 1, methine),

5,8-6,0 (M, 2, ArH),5.8-6.0 (M, 2, Ar H),

7,0-7,4 (M, 6, aromatické a vinylové protony),7.0-7.4 (M, 6, aromatic and vinyl protons),

10,0 (S, 1, fenolický proton),10.0 (S, 1, phenolic proton),

13,3 (b.d., S, 1, hydroxyl), dl-5-Hydroxy-3-hydroxyimethylen-2,2-dimethyl-7- [ 2- (4-fenyltíutyloxy) -4-chromanon, ole).13.3 (b.d., S, 1, hydroxyl), dl-5-Hydroxy-3-hydroxyimethylene-2,2-dimethyl-7- [2- (4-phenylthietyloxy) -4-chromanone, ole).

dl-5-Hydroxy-3-hydroxymethylen-2,2-dimethyl-7-cyklotiexyloxy-4-chroímamon:dl-5-Hydroxy-3-hydroxymethylene-2,2-dimethyl-7-cyclothyloxyloxy-4-chromamone:

IČ: (KBr) C = O 1620 cm1, OH 3420 cm1. MS: (Molekulární ion) 318.IR: (KBr) C = O 1620 cm -1 , OH 3420 cm -1 . MS: (Molecular ion) 318.

NMR: δ ™3 NMR: δ ™ 3

1,1-2,3 (M, 10, C5H10-cyklohexyi),1.1-2.3 (M, 10, C 5 H 10 -cyclohexyl),

I, 55 (S, 6, gem.dimethyl),I.55 (S, 6, gem.dimethyl),

4.1- 4,5 (M, 1, cyklohexyl-methinyl),4.1- 4.5 (M, 1, cyclohexylmethynyl),

3,9-6,1 (M, 2, ArH),3.9-6.1 (M, 2, Ar H),

7.1- 7,5 (d, 1, methinyl),7.1-7.5 (d, 1, methinyl),

II, 6 (S, 1, hydroxyl, D2O překrytí).II, 6 (S, 1, hydroxyl, D 2 O overlap).

dl-5-Hydroxy-3-hydroxymethylen-2,2-dimethyl-7- (l-methyl-3-fenoxypropyl) -4-chromanon, olej (ze sloučeniny podle příkladu 1):dl-5-Hydroxy-3-hydroxymethylene-2,2-dimethyl-7- (1-methyl-3-phenoxypropyl) -4-chromanone, oil (from the compound of Example 1):

Rf = 0,42 (silikagel, benzen-ethylacetát 18 : 1).R f = 0.42 (silica gel, benzene-ethyl acetate 18: 1).

MS: (molekulární ion) 368.MS: (molecular ion) 368.

Claims (1)

P Ř E D Μ Ε ΤP R E D Ε Ε Τ Způsob přípravy 3-hydroxymethylenchromianonu obecného vzorce I kdeA process for the preparation of 3-hydroxymethylene-chromianone of the formula I wherein Rz, a R5 jsou atotay vodíku, methyly nebo ethyly,R 2 and R 5 are hydrogen, methyl or ethyl, Z je alkylen s 1 až 9 atomy uhlíku nebo skupina —(alki)m—X—(alk2]n— kde každý ze substitiuentů (alkj a (alk2) obsahuje od 1 d'Oi 9 atomů uhlíku, přičemž součet atomů uhlíku v (alktj a (alk,) jei nejvýše 9, mi a n je 0 nebo 1,Z is C 1 -C 9 alkylene or - (alki) m —X- (alk 2 ] n - wherein each of the substituents (alkj and (alk 2 ) contains from 1'O 19 to 9 carbon atoms, the sum of the carbon atoms v (alk t ja (alk,) is not more than 9, m and n is 0 or 1, X je O, S, SO nebo- SO2 aX is O, S, SO or -SO 2 a VYNALEZUVYNALEZU W je methyl, fenyl, p-chlorfenyl, p-fluorfenyl, pyridyl, piperidyl, cykloalkyl s 3 až 7 atomy uhlíku, který je popřípadě monosubstituován a kde substituenty jsou fenyl, p-chlorfenyl nebo p-fluorfenyl, přičemž jestliže W je methyl, je Z— (alkj )m— —X—(alk2)n, vyznačený tím, že se sloučenina obecného vzorce II kdeW is methyl, phenyl, p-chlorophenyl, p-fluorophenyl, pyridyl, piperidyl, C 3 -C 7 cycloalkyl which is optionally monosubstituted and wherein the substituents are phenyl, p-chlorophenyl or p-fluorophenyl, wherein W is methyl, is Z- (alkj) m - X - (alk 2 ) n , characterized in that the compound of formula II wherein: Rj, R4, R5, Z a W mají výše uvedený význam;, nechá reagovat s ethylformiátem v přítomnosti hydridu sodného.R 1, R 4 , R 5 , Z and W are as defined above, reacted with ethyl formate in the presence of sodium hydride.
CS782293A 1975-11-03 1978-04-07 Method of preparatiob of 3-hydroxymethylenchromanone CS207573B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS782293A CS207573B2 (en) 1975-11-03 1978-04-07 Method of preparatiob of 3-hydroxymethylenchromanone

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62821075A 1975-11-03 1975-11-03
CS767070A CS207571B2 (en) 1975-11-03 1976-11-02 Method of preparation of new dibenzo/b,d/pyranes
CS782293A CS207573B2 (en) 1975-11-03 1978-04-07 Method of preparatiob of 3-hydroxymethylenchromanone

Publications (1)

Publication Number Publication Date
CS207573B2 true CS207573B2 (en) 1981-08-31

Family

ID=25746435

Family Applications (3)

Application Number Title Priority Date Filing Date
CS782292A CS207572B2 (en) 1975-11-03 1978-04-07 Method of preparation of dibenzo/b,d/pyrane
CS782293A CS207573B2 (en) 1975-11-03 1978-04-07 Method of preparatiob of 3-hydroxymethylenchromanone
CS793455A CS207574B2 (en) 1975-11-03 1979-05-18 Method of preparation of dibenzo/b,d/pyranes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CS782292A CS207572B2 (en) 1975-11-03 1978-04-07 Method of preparation of dibenzo/b,d/pyrane

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS793455A CS207574B2 (en) 1975-11-03 1979-05-18 Method of preparation of dibenzo/b,d/pyranes

Country Status (1)

Country Link
CS (3) CS207572B2 (en)

Also Published As

Publication number Publication date
CS207574B2 (en) 1981-08-31
CS207572B2 (en) 1981-08-31

Similar Documents

Publication Publication Date Title
US4696949A (en) Novel tri-phenyl alkane and alkene derivatives and their preparation and use
Kabbe et al. Synthesis and reactions of 4‐chromanones
CA1185977A (en) 1,1,2-triphenyl-ethane or ethylene compounds
US5939452A (en) Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4&#39; (LTB4) antagonists
US5102895A (en) Novel vitamin e derivatives and process for the production thereof
US4143139A (en) 9-Hydroxydibenzo[b,d]pyrans and intermediates
FI79707C (en) ANTIKOAGULANTER AV 4-HYDROXIKUMARINTYP, DERAS FRAMSTAELLNING SAMT DESSA INNEHAOLLANDE RAOTTGIFTSKOMPOSITIONER (BETEN).
CZ278567B6 (en) Process for preparing derivatives of benzocycloalkenyl dihydroxyalkanoic acids
US4018824A (en) 1-Aryloxy-3-aminopropane derivatives
US4845121A (en) Aci-reductone compounds belonging to the 6,7-disubstituted-3,4-dihydro benzopyan-2H-one class having antiaggregatory properties
Patonay et al. Synthesis and cyclization of 1-(2-hydroxyphenyl)-2-propen-1-one epoxides: 3-hydroxychromanones and-flavanones versus 2-(1-hydroxyalkyl)-3-coumaranones
Balasubramanian et al. Novel reaction of o-phenolic Mannich bases with. alpha.-chloroacrylonitrile
CS207573B2 (en) Method of preparatiob of 3-hydroxymethylenchromanone
US4243674A (en) 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4118559A (en) 9-Hydroxyhexahydrodibenzo[O,d]pyrans, 1-substituted-9-hydroxyhexahydrodibenzo[b,d]pyrans and intermediates therefor
CZ366692A3 (en) 3-alkoxymethylquinolines and process for preparing thereof
Pfeil et al. Synthesis of Oxalactams (2-Morpholinones) from Aziridinium Tetrafluoroborates and Hydroxy Esters
US2192840A (en) Method of preparing quinuclidine and derivatives thereof
SU677660A3 (en) Method of producing chromanone derivatives
EP0027948A1 (en) Tetrahydro-fluorene compounds, processes for their preparation and pharmaceutical compositions thereof
KR102563123B1 (en) Method of manufacturing fisetin or its derivatives
US3595878A (en) Methoxyphenyl- and phenyl-dialkyl-alpha-pyrone nitriles
US5447942A (en) N-derivatives of (phenylethyl-β-ol) amine, a process for their preparation and pharamaceutical compositions containing the same
Nagarathnam A facile preparation of 2‐(2‐arylethyl)‐and 2‐(aminomethyl) indoles
NL8103710A (en) HETEROPROSTAGLANDINE DERIVATIVES AND METHOD FOR THE PREPARATION THEREOF.